Publication: DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
eLife Sciences Publications, Ltd
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Justa-Schuch, Daniela, Maria Silva-Garcia, Esther Pilla, Michael Engelke, Markus Kilisch, Christof Lenz, Ulrike Möller, Fumihiko Nakamura, Henning Urlaub, and Ruth Geiss-Friedlander. 2016. “DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk.” eLife 5 (1): e16370. doi:10.7554/eLife.16370. http://dx.doi.org/10.7554/eLife.16370.
Research Data
Abstract
The aminopeptidase DPP9 removes dipeptides from N-termini of substrates having a proline or alanine in second position. Although linked to several pathways including cell survival and metabolism, the molecular mechanisms underlying these outcomes are poorly understood. We identified a novel interaction of DPP9 with Filamin A, which recruits DPP9 to Syk, a central kinase in B-cell signalling. Syk signalling can be terminated by degradation, requiring the ubiquitin E3 ligase Cbl. We show that DPP9 cleaves Syk to produce a neo N-terminus with serine in position 1. Pulse-chases combined with mutagenesis studies reveal that Ser1 strongly influences Syk stability. Furthermore, DPP9 silencing reduces Cbl interaction with Syk, suggesting that DPP9 processing is a prerequisite for Syk ubiquitination. Consistently, DPP9 inhibition stabilizes Syk, thereby modulating Syk signalling. Taken together, we demonstrate DPP9 as a negative regulator of Syk and conclude that DPP9 is a novel integral aminopeptidase of the N-end rule pathway. DOI: http://dx.doi.org/10.7554/eLife.16370.001
Description
Other Available Sources
Keywords
Syk, DPP9, N-end rule, protein half-life, Cbl, B cell signalling, Human
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service